Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for Restenosis After Coronary Intervention (mini-COREA)
NCT00500279Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of celecoxib in coronary restenosis, sponsored by Seoul National University Hospital. Primary endpoint: Late luminal loss on quantitative coronary angiography at 6 months. Status: unknown.
02
Drugs
celecoxib
03
Conditions
coronary restenosis
Beyond the preview
Go deeper on NCT00500279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00500279.